Evolutionary Innovations (inbunden)
Format
Häftad (Paperback)
Språk
Engelska
Antal sidor
342
Utgivningsdatum
2000-03-01
Upplaga
New e.
Utmärkelser
Schumpeter Society book prize, 1996
Förlag
OUP Oxford
Illustratör/Fotograf
5 figures
Illustrationer
5figs.
Dimensioner
235 x 155 x 20 mm
Vikt
480 g
Antal komponenter
1
Komponenter
49:B&W 6.14 x 9.21 in or 234 x 156 mm (Royal 8vo) Perfect Bound on White w/Gloss Lam
ISBN
9780198297246

Evolutionary Innovations

The Business of Biotechnology

Häftad,  Engelska, 2000-03-01
1131
  • Skickas från oss inom 3-6 vardagar.
  • Fri frakt över 249 kr för privatkunder i Sverige.
Finns även som
This is a study of the commercial development and uses of genetic engineering from the 1970s onwards. Maureen McKelvey focuses on two firmsGenentech in the US, and Kabi in Swedenand compares their initiatives, activities, and organization as they brought knowledge to the market in the form of insulin and the human growth hormone. Evolutionary Innovations was awarded the Schumpeter Society book prize in 1996. For this paperback edition the author has written a new introduction in which she reflects upon the most recent developments in biotechnology.

Passar bra ihop

  1. Evolutionary Innovations
  2. +
  3. The SWOT Analysis: Using your Strength to overcome Weaknesses, Using Opportunities to overcome Threats

De som köpt den här boken har ofta också köpt The SWOT Analysis: Using your Strength to overc... av Lawrence G Fine (häftad).

Köp båda 2 för 1366 kr

Kundrecensioner

Har du läst boken? Sätt ditt betyg »

Fler böcker av Maureen McKelvey

Recensioner i media

Long Range Planning, vol 33, 2000 A very thorough piece of work

Övrig information

Maureen McKelvey is Associate Professor in the Department of Technology and Social Change, Linkoping University, Sweden.

Innehållsförteckning

Introduction; Evolutionary Innovations; Science and Technology Interacting; Understanding Genetic Engineering; Generating Research; The Early- to Mid-1970s; Generating Research; The Mid- to Late-1970s; Specific Firm Challenges, 1979-83; Multiple Uses and Markets for Human Growth Hormone; Conclusions for Evolutionary Economics; Conclusions for Science and Technology